Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer
M. Martinez Palau (Terrassa, Spain), B. Garcia Cabo (Terrassa, Spain), T. Pribic (Terrassa, Spain), B. Barreiro Lopez (Terrassa, Spain), L. Esteban Tejero (Terrassa, Spain), R. Rami Porta (Terrassa, Spain), S. Call Caja (Terrassa, Spain), C. Obiols Fornell (Terrassa, Spain), M. Serra Mitjans (Terrassa, Spain), J. Sanz Santos (Terrassa, Spain)
Source: Virtual Congress 2020 – Screening and early lung cancer
Session: Screening and early lung cancer
Session type: E-poster session
Number: 1615
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Martinez Palau (Terrassa, Spain), B. Garcia Cabo (Terrassa, Spain), T. Pribic (Terrassa, Spain), B. Barreiro Lopez (Terrassa, Spain), L. Esteban Tejero (Terrassa, Spain), R. Rami Porta (Terrassa, Spain), S. Call Caja (Terrassa, Spain), C. Obiols Fornell (Terrassa, Spain), M. Serra Mitjans (Terrassa, Spain), J. Sanz Santos (Terrassa, Spain). Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer. 1615
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019
Determination of distant metastases in non-small cell lung cancer and factors related to presence of metastasis Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Carbohydrate-induced conformational MUC1 tumor-epitope correlates with improved post-surgical survival of non-small cell lung cancer patients with local or distant metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 150s Year: 2006
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm Source: Eur Respir J 2010; 36: 1355-1361 Year: 2010
Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017
Early recurrence in complete resected non-small cell lung cancer patients Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006
Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy? Source: Eur Respir J 2004; 24: Suppl. 48, 479s Year: 2004
A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005
Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004
Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002
Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Source: Eur Respir J 2009; 33: 1383-1388 Year: 2009